July 31, 2025
Live Stream Conference - Virtual
Course# MEP26001 - Department: Epidemiology and Biostatistics

Registration Fees

$400 Physicians

$350 Allied Health Professionals

$300 Residents/Fellows

Cancellation Policy

Cancellations received in writing before July 24, 2025 will be refunded, less a $75 administrative fee. No refunds will be made on cancellations received after that date. Please submit your cancellation request at
https://tiny.ucsf.edu/cmehelp

Registration fee discounts are available for Kaiser and UCSF CCMBM faculty. Please contact Lucy Wu at [email protected] for more information.

Overview

Now in its 22nd year, and presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. The course will critically review current treatment options. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis. Additional special topics this year include exercise for fall and fracture prevention, nutrition and skeletal health, and the approach to the premenopausal woman with low bone mass or skeletal fragility.

TARGET AUDIENCE
The course will provide an update on current recommendations about screening and treatment of osteoporosis for health care providers working with osteoporosis patients. It will also benefit researchers, technologists, and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. No prior clinical or scientific training in osteoporosis is required.

Live Stream Meeting
This course will be offered as a virtual conference. Login instructions along with the digital syllabus will be shared with the attendees a week before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.

Objectives

Screen for and diagnose osteoporosis according to the latest evidence-based standards of care;
Interpret dual-energy X-ray absorptiometry (DXA) bone density scans and avoid common DXA pitfalls;
Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies;
Assess the benefits and risks of continuing long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
Recommend physical activity to optimize bone health and to help patients with skeletal fragility move safely;
Provide evidence-based nutritional guidance for healthy bones;
Evaluate and treat, when appropriate, the premenopausal woman with low bone mass or skeletal fragility

Accreditation

Joint Accreditation with Commendation Logo In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

UCSF designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Outline

Thursday, July 31, 2025

SCREENING AND DIAGNOSIS
8:00 AM		Zoom Registration and login, housekeeping, overview
8:10	G	Osteoporosis Screening and Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis	Steven T. Harris, MD, FACP, FASBMR
8:50		Q&A
ANTIRESORPTIVE TREATMENT
9:00	G	Bisphosphonate Efficacy, Duration, and Drug Holidays: Maximize Benefits and Minimize Risk	Dennis M. Black, PhD
9:30		Q&A
9:40	G	Long-Term Treatment With and Following Denosumab	Karin Y. Wu, MD
10:10		Q&A
10:20		Break
ANABOLIC TREATMENT
10:35	G	Anabolic and Mixed Anabolic/Antiresorptive Agents: When, and How, and In Whom Use Them	Kelly Wentworth, MD
11:05		Q&A
11:15	G	Long-Term Management of Osteoporosis	Anne L. Schafer, MD
11:45		Q&A with the Panel of Morning Speakers	Kelly Wentworth, MD Anne L. Schafer, MD Karin Y. Wu, MD Dennis M. Black, PhD Steven T. Harris, MD, FACP, FASBMR Deborah E. Sellmeyer, MD (facilitator)
12:20 PM		Lunch Break (Zoom Livestream Closed During This Time)
SPECIAL TOPICS IN OSTEOPOROSIS
1:20 PM	G	Nutrition and Skeletal Health	Deborah E. Sellmeyer, MD
1:50		Q&A
2:00	G	Exercise for Fall and Fracture Prevention	Lora Giangregorio, PhD
2:30		Q&A
2:40		DXA Interpretation and Pitfalls	Deborah E. Sellmeyer, MD
3:10		Q&A
3:20		Break
3:35	G	Approach to the Premenopausal Woman with Low Bone Mass or Skeletal Fragility	Yumie Rhee, MD
4:05		Q&A
4:15	G	Clinical Roundtable: Q&A with a Panel of Physicians	Steven T. Harris, MD, FACP, FASBMR Deborah E. Sellmeyer, MD Karin Y. Wu, MD Tiffany Y. Kim, MD Anne L. Schafer, MD (facilitator)
5:00		Adjourn

Course Chairs

Dennis M. Black, PhD
Professor of Epidemiology and Biostatistics

Anne L. Schafer, MD
Professor of Medicine and of Epidemiology & Biostatistics, UCSF;
Endocrine Research Unit, San Francisco VA Medical Center

Faculty

(University of California, San Francisco unless indicated)

Search form

You are here

22nd Annual Osteoporosis: New Insights in Research, Diagnosis, and Clinical Care - 2025